menu
    • menu

    Company profile for Repertoire Immune Medicines

    NEW Drugs in Dev: 4
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Repertoire Immune Medicines, a Flagship Pioneering company, is a clinical stage biotechnology company working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is founded on the premise that the repertoire of TCR-antigen codes that drive health and disease represents one of the greatest opportunities for innovation in medical ...
    Repertoire Immune Medicines, a Flagship Pioneering company, is a clinical stage biotechnology company working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is founded on the premise that the repertoire of TCR-antigen codes that drive health and disease represents one of the greatest opportunities for innovation in medical science. The company harnesses and deploys the intrinsic ability of T cells to prevent and cure disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Repertoire Immune MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Kendall Square, Cambridge, Massachusetts, 02139
    Telephone
    Telephone
    (617) 949-5600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.repertoire.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/repertoire-immune-medicines/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Repertoire Immune Medicines Gets FDA Fast Track for RPTR-1-201
    Repertoire Immune Medicines Gets FDA Fast Track for RPTR-1-201

    07 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/repertoire-immune-medicines-announces-fda-fast-track-designation-for-its-investigational-immune-medicine-rptr-1-201-302764490.html

    PR NEWSWIRE
    07 May 2026
    Share Share
    Repertoire Doses First Participant in RPTR-1-201 Trial
    Repertoire Doses First Participant in RPTR-1-201 Trial

    23 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7205881

    FIRSTWORD PHARMA
    23 Apr 2026
    Share Share
    Repertoire, Lilly Partner on Autoimmune Diseases
    Repertoire, Lilly Partner on Autoimmune Diseases

    29 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/repertoire-immune-medicines-announces-strategic-collaboration-with-lilly-to-develop-tolerizing-therapies-for-autoimmune-diseases-302673203.html

    PR NEWSWIRE
    29 Jan 2026
    Share Share
    Flagship Pioneering, Repertoire Immune Medicines Partner
    Flagship Pioneering, Repertoire Immune Medicines Partner

    22 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/flagship-pioneering-and-repertoire-immune-medicines-announce-agreement-to-identify-t-cell-targeted-immune-medicines-for-prostate-cancer-under-strategic-partnership-with-pfizer-302647371.html

    PR NEWSWIRE BIO
    22 Dec 2025
    Share Share
    Genentech builds autoimmune Repertoire with $765M deal
    Genentech builds autoimmune Repertoire with $765M deal

    24 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/roches-genentech-builds-autoimmune-repertoire-deal-worth-765m

    FIERCE BIOTECH
    24 Apr 2025
    Share Share
    BMS pays $65M to expand Repertoire of autoimmune assets
    BMS pays $65M to expand Repertoire of autoimmune assets

    30 Apr 2024

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bms-pays-65m-expand-repertoire-autoimmune-assets

    Nick Paul Taylor FIERCE BIOTECH
    30 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search